Search by Drug Name or NDC
NDC 46163-0300-10 Sodium Chloride 900 mg/100mL Details
Sodium Chloride 900 mg/100mL
Sodium Chloride is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Medical Care de Mexico, S.A. de C.V.. The primary component is SODIUM CHLORIDE.
Product Information
| NDC | 46163-0300 |
|---|---|
| Product ID | 46163-300_0801932c-8861-35d8-e063-6294a90a67c1 |
| Associated GPIs | |
| GCN Sequence Number | 001210 |
| GCN Sequence Number Description | 0.9 % sodium chloride IV SOLN 0.9 % INTRAVEN |
| HIC3 | C1B |
| HIC3 Description | SODIUM/SALINE PREPARATIONS |
| GCN | 02962 |
| HICL Sequence Number | 008255 |
| HICL Sequence Number Description | 0.9 % SODIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Sodium Chloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sodium Chloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 900 |
| Active Ingredient Units | mg/100mL |
| Substance Name | SODIUM CHLORIDE |
| Labeler Name | Fresenius Medical Care de Mexico, S.A. de C.V. |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078177 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 46163-0300-10 (46163030010)
| NDC Package Code | 46163-300-10 |
|---|---|
| Billing NDC | 46163030010 |
| Package | 12 BAG in 1 CARTON (46163-300-10) / 1000 mL in 1 BAG |
| Marketing Start Date | 2007-04-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |